Hematology Analyzers Market Size & Share, by Product (3 Part Hematology Analyzer, 5 Part Hematology Analyzer, Point-of-Care Testing Hematology Analyzer); End-user (Hospitals, Clinical Laboratories, Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3295
  • Published Date: Aug 29, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Hematology Analyzers Market size was valued at USD 6.22 billion in 2023 and is expected to exceed USD 13.6 billion by 2036, expanding at over 6.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of hematology analyzers is assessed at USD 6.53 billion. The market for hematology analyzers is mainly projected to grow owing to factors such as the growing number of blood donations and rising incidences of blood disorders.  In 2018, more than 210,000 people were diagnosed with hemophilia, which increased up to about 324,000 in the year 2019. Moreover, the rising use of hematology analyzers in research and development activities in various areas such as pharmacogenomics, genetic therapies, bleeding disorders, stem cell research, and proteomics is also expected to propel market growth. Furthermore, factors such as the rise in public awareness and the consolidation of diagnostic laboratory chains are expected to drive the market growth in the forecast period. Additionally, the rising adoption rate of automated hematology instruments and integration of AI-based hematology analyzers combined with growing preferences towards high sensitivity hematology testing is also anticipated to drive the market growth in the near future.


Get more information on this report: Request Free Sample PDF

Hematology Analyzers Sector: Growth Drivers and Challenges

Growth Drivers

  • Growth in Blood Donations
  • Increasing Technological Advancements in Hematology Analyzers

Challenges

  • Stringent Regulatory Policies for Hematology Analyzers
  • High Cost of Hematology Analyzers

Hematology Analyzers Market: Key Insights

Base Year

2023

Forecast Year

2024–2036

CAGR

6.2%

Base Year Market Size (2023)

USD 6.22 billion

Forecast Year Market Size (2036)

USD 13.6 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Hematology Analyzers Segmentation

The market is segmented based on product type into 3-part hematology analyzer, 5-part hematology analyzer, point-of-care testing hematology analyzer, and others. The 3-part hematology analyzer segment is anticipated to grab the most significant share by the end of 2030, ascribing to the fact that 3-part hematology provides sufficient information for most clinical settings and is highly cost-effective. 

Based on end-users, the clinical laboratories segment in the global hematology analyzers market is projected to grow with a significant CAGR over the forecast period. The segment's growth can be attributed to the fact that clinical laboratories are early adopters of advanced technological equipment, and an increasing number of hematological tests are conducted here. Moreover, as clinical laboratories provide convenience and accurate results, the market segment is expected to grow significantly in the upcoming years.

Our in-depth analysis of the global market includes the following segments:

           Product Type

  • 3-Part Hematology Analyzer
  • 5-Part Hematology Analyzer
  • Point-Of-Care Testing Hematology Analyzer
  • Others

             End-users

  • Hospitals
  • Clinical Laboratories
  • Research Institutes
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Hematology Analyzers Industry - Regional Synopsis

Geographically, the global hematology analyzers market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific is estimated to dominate majority revenue share by 2036, attributed to presence of emerging opportunities, mainly in the developing economies of China and India. Moreover, growing awareness regarding better health care facilities, rising occurrences of diseases, and increasing population in the countries are also expected to fuel the growth of the market in the region. Furthermore, in 2030, the market in North America is evaluated to occupy the largest share in terms of revenue owing to the increasing burden of blood disorders in the region.  For instance, according to the World Health Organization, anemia which is a common blood disorder, affects more than three million Americans, particularly adolescent women. Additionally, the growth in the adoption of hematology analyzers by the diagnostic industry and growing technological advancements in diagnostic instruments in the region are expected to fuel market growth in the future.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Hematology Analyzers Landscape

    • Sysmex Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Abbott Laboratories
    • Beckman Coulter
    • HORIBA Ltd
    • Siemens AG
    • Nihon Kohden Corporation
    • Bio-Rad Laboratories
    • Mindray Medical International Ltd.
    • Roche Diagnostics
    • Boule Diagnostics AB

In the News

  • May 2021: Sysmex Corporation, a manufacturer of medical equipment and devices, has signed deals of joint development and investment with biotechnology startup ThinkCyte to produce and sell a new artificial intelligence-enabled cell analysis technology for in-vitro diagnostics.

Author Credits:  Radhika Pawar


  • Report ID: 3295
  • Published Date: Aug 29, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of hematology analyzers is assessed at USD 6.53 billion.

Hematology Analyzers Market size was valued at USD 6.22 billion in 2023 and is expected to exceed USD 13.6 billion by 2036, expanding at over 6.2% CAGR during the forecast period i.e., between 2024-2036. The growth in blood donations and increasing technological advancements in hematology analyzers will fuel the market growth.

Asia Pacific is estimated to dominate majority revenue share by 2036, attributed to presence of emerging opportunities, mainly in the developing economies of China and India.

The major players in the market include Abbott Laboratories, Beckman Coulter, HORIBA Ltd, Siemens AG, Nihon Kohden Corporation, among others.
Hematology Analyzers Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample